Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints

English version České info

Jan Hontelez and colleagues argue that the cost-effectiveness studies of HIV treatment scale-up need to include health system constraints to be more informative.

Vyšlo v časopise: Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints. PLoS Med 14(2): e32767. doi:10.1371/journal.pmed.1002240
Kategorie: Essay
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002240

Souhrn

Jan Hontelez and colleagues argue that the cost-effectiveness studies of HIV treatment scale-up need to include health system constraints to be more informative.

Zdroje

1. UNAIDS. Global AIDS Update 2016. Geneva: Joint United Nations Programme on HIV/AIDS, 2016.

2. Hontelez JAC, Chang A, Ogbuoji O, de Vlas SJ, Bärnighausen T, Atuna R. Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: Investment needs, population health gains, and cost-effectiveness. AIDS. 2016;30(15):2341–50. doi: 10.1097/QAD.0000000000001190 27367487

3. Kates J, Wexler A, Lief E. Financing the response to HIV in Low-and Middle- Income Countries: International Assistance from Donor Governments in 2014. Washington: Kaiser Family Foundation & UNAIDS 2015. http://www.unaids.org/sites/default/files/media_asset/financing-the-response-to-HIV-in-low-and-middle-income-countries_en.pdf

4. The World Health Organisation. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: WHO, 2015.

5. SSP Stockouts National Survey 2016. Stop Stockouts, 2016. http://www.groundup.org.za/media/uploads/documents/StopStockoutsSurvey2016.pdf

6. Shubber Z, Mills EJ, Nachega JB, Vreeman R, Freitas M, Bock P, et al. Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis. PLoS Med. 2016;13(11):e1002183. doi: 10.1371/journal.pmed.1002183 27898679

7. Hauck K, Thomas R, Smith PC. Departures from Cost-Effectiveness Recommendations: The Impact of Health System Constraints on Priority Setting. Health Systems & Reform. 2016;2(1):61–70.

8. The World Health Organization. Everybody's business. Strenghtening health systems to improve health outcomes. WHO's framework for action. Geneva: WHO, 2007.

9. Meyer-Rath G, Over M. HIV treatment as prevention: modelling the cost of antiretroviral treatment—state of the art and future directions. PLoS Med. 2012;9(7):e1001247. doi: 10.1371/journal.pmed.1001247 22802731

10. Cleary SM, McIntyre D, Boulle AM. Assessing efficiency and costs of scaling up HIV treatment. AIDS. 2008;22 Suppl 1:S35–42.

11. Fraser N, Kerr CC, Harouna Z, Alhousseini Z, Cheikh N, Gray R, et al. Reorienting the HIV response in Niger toward sex work interventions: from better evidence to targeted and expanded practice. J Acq Immun Def Synd. 2015;68 Suppl 2:S213–20.

12. Anderson SJ, Cherutich P, Kilonzo N, Cremin I, Fecht D, Kimanga D, et al. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet. 2014;384(9939):249–56. doi: 10.1016/S0140-6736(14)61053-9 25042235

13. Cornell M, L R, Fox MP, Garone DB, Giddy J, Fenner L, et al. Mortality among adults transferred and lost to follow-up from antiretroviral therapy programmes in South Africa: a multicenter cohort study. J Acq Immun Def Synd. 2014;67(2):e67–75.

14. Daniels N. Accountability for reasonableness. Establishing a fair process for priority setting is easier than agreeing on principles. Brit Med J. 2000;321(7272):1300–1. 11090498